This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.
